LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Benaroya Research Institute
Headquarters:
Seattle, WA, United States of America
Website:
https://www.benaroyaresearch...
Year Founded:
1956
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Aug 3, 2024
Deals
Biotechs find problem-solving in academia, and mostly outside the big hubs
Academia-biotech deals span innovative assets to tissue bank resources to enabling technologies
Read More
BioCentury
|
Aug 12, 2021
Product Development
GentiBio champions build-a-Treg approach with $157M series A
The newco is the latest to indicate Treg manufacturing will be an in-house affair
Read More
BioCentury
|
Aug 11, 2020
Emerging Company Profile
GentiBio: combining trio of platforms to enhance Treg therapies
Launches with $20M to engineer stable, tunable and tissue-specific Treg cell therapies
Read More
BioCentury
|
Dec 14, 2018
Financial News
Allen Insitute's immunology division launches with $125M, Lilly vet and five partners
Read More
BioCentury
|
Dec 13, 2018
Preclinical News
Allen Institute's immunology division launches with $125M, Lilly vet and five partners
Read More
BioCentury
|
Apr 4, 2018
Translation in Brief
Targeting TSLP
How TSLP contributes to breast tumor cell growth
Read More
BioCentury
|
Apr 3, 2018
Distillery Therapeutics
Cancer
Read More
BioCentury
|
May 12, 2011
Distillery Techniques
Technology: Drug delivery
Read More
BioCentury
|
Sep 11, 2008
Targets & Mechanisms
Skin-deep Target
Read More
BioCentury
|
Sep 24, 2007
Company News
VLST management update
Read More
Items per page:
10
1 - 10 of 10